Mc Ilrath & Eck, LLC Sanofi Transaction History

Mc Ilrath & Eck, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$45.75 - $52.48 $16,149 - $18,525	353 Added 57.59%	966 $46,000
Q4 2023 Feb 05, 2024	BUY	$43.13 - $54.79 $15,569 - $19,779	361 Added 143.25%	613 $30,000
Q1 2023 May 08, 2023	BUY	$45.86 - $54.45 $11,556 - $13,721	252 New	252 $13,000
Q2 2022 Jul 29, 2022	SELL	$48.99 - $57.46 $13,227 - $15,514	-270 Closed	0 $0
Q2 2020 Aug 04, 2020	SELL	$42.91 - $52.5 $3,003 - $3,675	-70 Reduced 20.59%	270 $14,000
Q1 2020 May 14, 2020	BUY	$38.02 - $51.66 $2,661 - $3,616	70 Added 25.93%	340 $15,000
Q1 2019 May 07, 2019	SELL	$40.83 - $45.43 $14,412 - $16,036	-353 Reduced 56.66%	270 $12,000
Q2 2018 Aug 07, 2018	BUY	$37.63 - $41.22 $23,443 - $25,680	623 New	623 $25,000

807

270M

1.9M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $134B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of Mc Ilrath & Eck, LLC, based on Form 13F filings with the SEC.

Stay updated on Mc Ilrath & Eck, LLC with notifications on news.